QA: Catalent Inc in us_pharma/2023

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001596783_2024_Catalent_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001596783, Catalent Inc

  xvar xval
0 AssetsCurrent 2,692,000,000
1 IntangibleAssetsNetIncludingGoodwill 4,019,000,000
2 PropertyPlantAndEquipmentNet 3,682,000,000
3 remainder_Assets 384,000,000
4 LiabilitiesCurrent 1,530,000,000
5 LiabilitiesNoncurrent 147,000,000
6 remainder_Liabilities 4,489,000,000
7 CostOfGoodsAndServicesSold 3,240,002,902
8 SellingGeneralAndAdministrativeExpense 825,703,978
9 ResearchAndDevelopmentExpense 0
10 remainder_Expenses 277,941,114
11 remainder_Revenues 4,134,669,897
12 remainder_NetIncome -171,534,486
13 remainder_ComprehensiveNetIncome -8,494,607
  yvar yval
0 Assets 10,777,000,000
1 Liabilities 6,166,000,000
2 Expenses 4,343,647,994
3 Revenues 4,134,669,897
4 StockholdersEquity 4,611,000,000
5 NetIncome -380,512,583
6 ComprehensiveNetIncome -384,759,886
7 BaseVar 12,800,673,492
8 EconomicCapitalRatiobeforeLimitedLiability 1.14
9 EconomicCapitalRatio 2.41

Edgar->Model Mapping

Feature Distribution

Change over Time